000153919 001__ 153919
000153919 005__ 20240229123054.0
000153919 0247_ $$2doi$$a10.3389/fonc.2020.00147
000153919 0247_ $$2pmid$$apmid:32154164
000153919 0247_ $$2pmc$$apmc:PMC7046686
000153919 0247_ $$2altmetric$$aaltmetric:77333500
000153919 037__ $$aDKFZ-2020-00529
000153919 041__ $$aeng
000153919 082__ $$a610
000153919 1001_ $$0P:(DE-HGF)0$$aPeukert, Xenia$$b0$$eFirst author
000153919 245__ $$aHippocampus-Related Cognitive and Affective Impairments in Patients With Breast Cancer-A Systematic Review.
000153919 260__ $$aLausanne$$bFrontiers Media$$c2020
000153919 3367_ $$2DRIVER$$aarticle
000153919 3367_ $$2DataCite$$aOutput Types/Journal article
000153919 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1601034487_17569$$xReview Article
000153919 3367_ $$2BibTeX$$aARTICLE
000153919 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000153919 3367_ $$00$$2EndNote$$aJournal Article
000153919 500__ $$a#EA:C110#LA:C110#
000153919 520__ $$aBackground: Although improvements in medical treatment lead to a steadily rising survival rate of breast cancer patients (BCP), it is associated with a decrease in cognitive and affective function. The hippocampus, a brain region with a high influence on both cognitive and affective function, is increasingly becoming the focus of current research because of its high vulnerability to adverse direct (chemotherapeutic agents, endocrine therapeutic agents, and radiation) or indirect (stress and other psycho-social factors) treatment-related effects. Methods: This systematic review analyses current data from literature combining hippocampus-related brain changes due to breast cancer treatment with associated cancer-related cognitive and affective impairments (CRCI/CRAI). The seven studies that met the inclusion criteria consisted of six cross-sectional studies and one longitudinal study. Results: The study results indicate hippocampal differences across all types of treatment. Those differences include volume loss, deformation, and changes in functional connectivity. They are associated with CRCI, revealing executive function as well as working memory, episodic memory, and prospective memory as the most affected domains. Although an interaction between hippocampus-related brain changes, CRCI, and CRAI can be hypothesized, CRAI are less reflected in current research. Discussion: More research including longitudinal assessments with better overall methodology is needed to fully understand the interaction between hippocampal alterations and both CRCI and CRAI due to breast cancer treatment.
000153919 536__ $$0G:(DE-HGF)POF3-313$$a313 - Cancer risk factors and prevention (POF3-313)$$cPOF3-313$$fPOF III$$x0
000153919 588__ $$aDataset connected to CrossRef, PubMed,
000153919 7001_ $$0P:(DE-He78)a0c2037d9054be26907a05ae520d5756$$aSteindorf, Karen$$b1$$udkfz
000153919 7001_ $$aSchagen, Sanne B$$b2
000153919 7001_ $$aRunz, Adrian$$b3
000153919 7001_ $$aMeyer, Patric$$b4
000153919 7001_ $$0P:(DE-He78)d05b24af674d8ef2c455634434b67770$$aZimmer, Philipp$$b5$$eLast author$$udkfz
000153919 773__ $$0PERI:(DE-600)2649216-7$$a10.3389/fonc.2020.00147$$gVol. 10, p. 147$$p147$$tFrontiers in oncology$$v10$$x2234-943X$$y2020
000153919 909CO $$ooai:inrepo02.dkfz.de:153919$$pVDB
000153919 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000153919 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)a0c2037d9054be26907a05ae520d5756$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000153919 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)d05b24af674d8ef2c455634434b67770$$aDeutsches Krebsforschungszentrum$$b5$$kDKFZ
000153919 9131_ $$0G:(DE-HGF)POF3-313$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vCancer risk factors and prevention$$x0
000153919 9141_ $$y2020
000153919 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bFRONT ONCOL : 2017
000153919 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000153919 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000153919 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000153919 915__ $$0StatID:(DE-HGF)0320$$2StatID$$aDBCoverage$$bPubMed Central
000153919 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal
000153919 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ
000153919 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Blind peer review
000153919 915__ $$0LIC:(DE-HGF)CCBYNV$$2V:(DE-HGF)$$aCreative Commons Attribution CC BY (No Version)$$bDOAJ
000153919 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List
000153919 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000153919 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000153919 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine
000153919 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5
000153919 9202_ $$0I:(DE-He78)C110-20160331$$kC110$$lBewegung, Präventionsforschung und Krebs$$x0
000153919 9200_ $$0I:(DE-He78)C110-20160331$$kC110$$lBewegung, Präventionsforschung und Krebs$$x0
000153919 9201_ $$0I:(DE-He78)C110-20160331$$kC110$$lBewegung, Präventionsforschung und Krebs$$x0
000153919 980__ $$ajournal
000153919 980__ $$aVDB
000153919 980__ $$aI:(DE-He78)C110-20160331
000153919 980__ $$aUNRESTRICTED